Mergers and acquisitions
The integrated platform will combine patient engagement, care access, provider data management, price transparency and payment tools.
Dr. Peter Chang, associate professor of radiological science and computer science at UCI, joins True-See's clinical advisory board.
The deal marks Innovaccer's fourth acquisition in the past two years.
The acquisition brings together mPulse’s AI-driven engagement tools with Clarity’s healthcare communication platform.
The acquisition expands Teladoc's specialist network and presence in the region, while the company navigates ongoing financial challenges.
The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.
Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.
Proceeds will go to settling debts and focusing on its business in the United States.
The acquisition, part of a strategic partnership to accelerate Arcadia's growth and innovation, marks an exit for former investor Peloton Equity.
Christopher McGhee says that, along with the acquisition, Current Health will have a "return to scrappiness and that startup spirit."